These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26076870)
1. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Aydin M; Altintas N; Cem Mutlu L; Bilir B; Oran M; Tülübaş F; Topçu B; Tayfur İ; Küçükyalçin V; Kaplan G; Gürel A Clin Respir J; 2017 May; 11(3):318-327. PubMed ID: 26076870 [TBL] [Abstract][Full Text] [Related]
2. Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation. Tajti G; Gesztelyi R; Pak K; Papp C; Keki S; Szilasi ME; Mikaczo A; Fodor A; Szilasi M; Zsuga J Int J Chron Obstruct Pulmon Dis; 2017; 12():873-884. PubMed ID: 28352168 [TBL] [Abstract][Full Text] [Related]
3. Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease? Telo S; Kırkıl G; Kuluöztürk M; Balin M; Deveci F Clin Respir J; 2018 Apr; 12(4):1433-1438. PubMed ID: 28756635 [TBL] [Abstract][Full Text] [Related]
4. Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD. Zinellu A; Fois AG; Sotgia S; Sotgiu E; Zinellu E; Bifulco F; Mangoni AA; Pirina P; Carru C PLoS One; 2016; 11(8):e0160237. PubMed ID: 27479314 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826 [TBL] [Abstract][Full Text] [Related]
6. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD. Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840 [TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD). Scott JA; Duongh M; Young AW; Subbarao P; Gauvreau GM; Grasemann H Int J Mol Sci; 2014 Apr; 15(4):6062-71. PubMed ID: 24727374 [TBL] [Abstract][Full Text] [Related]
8. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker. Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T COPD; 2016; 13(2):139-45. PubMed ID: 26514682 [TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD. Csoma B; Bikov A; Nagy L; Tóth B; Tábi T; Szűcs G; Komlósi ZI; Müller V; Losonczy G; Lázár Z Respir Res; 2019 Jul; 20(1):156. PubMed ID: 31311549 [TBL] [Abstract][Full Text] [Related]
10. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related]
11. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483 [TBL] [Abstract][Full Text] [Related]
12. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868 [TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease]. Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428 [TBL] [Abstract][Full Text] [Related]
15. Systemic concentrations of asymmetric dimethylarginine (ADMA) in chronic obstructive pulmonary disease (COPD): state of the art. Zinellu A; Fois AG; Mangoni AA; Paliogiannis P; Sotgiu E; Zinellu E; Marras V; Pirina P; Carru C Amino Acids; 2018 Sep; 50(9):1169-1176. PubMed ID: 29951704 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease. Kirbas S; Kirbas A; Tufekci A; Cumhur Cure M; Cakmak S; Yazici T; Cure E Acta Clin Belg; 2016 Apr; 71(2):71-5. PubMed ID: 27075796 [TBL] [Abstract][Full Text] [Related]
17. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis. Bilgiç Ö; Altınyazar HC; Baran H; Ünlü A Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188 [TBL] [Abstract][Full Text] [Related]
18. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level. Saitoh M; Osanai T; Kamada T; Matsunaga T; Ishizaka H; Hanada H; Okumura K Heart Vessels; 2003 Sep; 18(4):177-82. PubMed ID: 14520484 [TBL] [Abstract][Full Text] [Related]
19. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938 [TBL] [Abstract][Full Text] [Related]
20. High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD. Cao WJ; Li MH; Li JX; Xu X; Ren SX; Rajbanshi B; Xu JF COPD; 2016; 13(2):160-6. PubMed ID: 26488201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]